Preview: Aquestive Therapeutics's Earnings
Portfolio Pulse from Benzinga Insights
Aquestive Therapeutics (NASDAQ:AQST) is set to release its latest quarterly earnings report on November 6, 2023. Analysts estimate an earnings per share (EPS) of $-0.11. The company's stock price has historically been affected more by its guidance than its earnings performance. Last quarter, the company beat EPS by $0.01, resulting in a 5.37% drop in the share price the next day. Over the last 52-week period, shares are up 69.66%.
November 03, 2023 | 8:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Aquestive Therapeutics is expected to report an EPS of $-0.11. The company's stock price has been more affected by its guidance than its earnings performance. Last quarter, the company beat EPS by $0.01, resulting in a 5.37% drop in the share price the next day.
The company's stock price has historically been more affected by its guidance than its earnings performance. Therefore, while the estimated EPS is negative, the impact on the stock price will depend more on the company's guidance for the next quarter. Last quarter, despite beating the EPS estimate, the stock price dropped by 5.37% the next day.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100